We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+31.01%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.93B
AUM Growth
+$1.86B
Cap. Flow
+$1.22B
Cap. Flow %
31.06%
Top 10 Hldgs %
44.77%
Holding
2,316
New
544
Increased
345
Reduced
243
Closed
1,102

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$208M
2
TSLA icon
Tesla
TSLA
+$33.2M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$28M
4
BHF icon
Brighthouse Financial
BHF
+$18.6M
5
GLD icon
SPDR Gold Trust
GLD
+$17.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 9.72%
2 Technology 5.35%
3 Industrials 3.23%
4 Financials 2.61%
5 Communication Services 2.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KBAL
2151
DELISTED
Kimball International
KBAL
-500
Closed -$5K
MNTV
2152
DELISTED
Momentive Global Inc. Common Stock
MNTV
-4,858
Closed -$107K
TA
2153
DELISTED
TravelCenters of America LLC
TA
-100
Closed -$2K
JNCE
2154
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-200
Closed -$2K
MAXR
2155
CALL
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
-3,800
Closed -$95K
CSII
2156
DELISTED
Cardiovascular Systems, Inc.
CSII
-100
Closed -$4K
AUY
2157
CALL
DELISTED
Yamana Gold, Inc.
AUY
-200
Closed -$1K
AIMC
2158
DELISTED
Altra Industrial Motion Corp
AIMC
-200
Closed -$9.85K
CNCE
2159
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-1,666
Closed -$16K
ALBO
2160
PUT
DELISTED
Albireo Pharma Inc
ALBO
-100
Closed -$3K
OPNT
2161
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
-1,400
Closed -$10K
SRNE
2162
PUT
DELISTED
Sorrento Therapeutics, Inc.
SRNE
-400
Closed -$4K
LHCG
2163
DELISTED
LHC Group LLC
LHCG
-551
Closed -$117K
LCI
2164
DELISTED
Lannett Company, Inc.
LCI
-1,856
Closed -$45K
STOR
2165
DELISTED
STORE Capital Corporation
STOR
-5,744
Closed -$158K
IVC
2166
DELISTED
Invacare Corporation
IVC
-160
Closed -$1K
SJI
2167
DELISTED
South Jersey Industries, Inc.
SJI
-1,946
Closed -$37K
VIVO
2168
DELISTED
Meridian Bioscience Inc
VIVO
-318
Closed -$5K
BNFT
2169
DELISTED
Benefitfocus, Inc.
BNFT
-300
Closed -$3K
TCDA
2170
DELISTED
Tricida, Inc. Common Stock
TCDA
-300
Closed -$3K
SPNE
2171
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
-200
Closed -$3K
OYST
2172
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
-200
Closed -$4K
ABMD
2173
CALL
DELISTED
Abiomed Inc
ABMD
-300
Closed -$83K
ECOM
2174
DELISTED
CHANNELADVISOR CORPORATION
ECOM
-800
Closed -$12K
CVET
2175
DELISTED
Covetrus, Inc. Common Stock
CVET
-4,568
Closed -$111K

Similar funds

Prelude Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Prelude Capital Management held 2,316 positions worth $3.93B, up 90% from $2.07B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Prelude Capital Management deployed $1.22B of net new capital in Q4 2020, opening 544 new positions and adding to 345 existing holdings. Its largest new stake was Tesla: 194,520 shares worth $45.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 9.7% of assets, up from 4.7% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Alibaba, an estimated $6.78M trimmed.

  • Prelude Capital Management's largest Q4 2020 buy was Tesla: 194,520 shares worth $45.8M.
  • Prelude Capital Management added most to Amazon in Q4 2020, an estimated $208M increase.
  • Prelude Capital Management's biggest Q4 2020 reduction was Alibaba, cutting an estimated $6.78M.
  • Prelude Capital Management fully exited iShares 0-5 Year High Yield Corporate Bond ETF in Q4 2020, selling an estimated $24.2M.
  • Prelude Capital Management's ten largest holdings make up 45% of its $3.93B portfolio in Q4 2020.
  • Prelude Capital Management opened 544 new positions and closed 1,102 in Q4 2020.
  • Prelude Capital Management's portfolio value rose 90% quarter-over-quarter to $3.93B.

Based on Prelude Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.